Newer Mechanisms in Anxiety Drug R&D

Tankosic, Timothy M.D.

• This article was written by Timothy Tankosic, M.D. He may be contacted via email at [email protected].

Reprints of this article are available. For more information visit www.drugandmarket.com/journal and click the "Reprints" link.

Drug & Market Development 17(3):p 1287-1891, March 2006.

• Compared to only a few years ago, the current anxiety drug development pipeline is more diverse with regard to the mechanisms of action of drug candidates, some of which have now entered mid- to late-stage clinical development.

• Table 6 lists select drugs in clinical development for anxiety.

TABLE 6 Select Drugs in Development for Anxiety
Open multimedia modal

TABLE 6 CONTINUED Select Drugs in Development for Anxiety
Open multimedia modal

• This article highlights primarily developmental candidates for anxiety that have newer mechanisms of action.

Newer Mechanisms in Anxiety Drug R&D

TABLE 6 Select Drugs in Development for Anxiety

TABLE 6 CONTINUED Select Drugs in Development for Anxiety